BPI-23314: A novel orally bioavailable small molecular BET inhibitor with target protein degradation activity

被引：0
|
作者：
Guo, Jing [1 ]
Xu, Yan [1 ]
Yan, Dan [1 ]
Yu, Bo [1 ]
Yu, Weiwei [1 ]
Chen, Haibo [1 ]
Xu, Xiaofeng [1 ]
Liu, Xiangyong [1 ]
Lan, Hong [1 ]
Ding, Lieming [1 ]
Wang, Jiabing [1 ]
机构：
[1] Betta Pharmaceut Co LTD, Hangzhou, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-1751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1751
引用
收藏
页数：2
相关论文
共 50 条
  • [41] YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
    Yong Xia
    Xuejiao Song
    Deliang Li
    Tinghong Ye
    Youzhi Xu
    Hongjun Lin
    Nana Meng
    Guobo Li
    Senyi Deng
    Shuang Zhang
    Li Liu
    Yongxia Zhu
    Jun Zeng
    Qian Lei
    Youli Pan
    Yuquan Wei
    Yinglan Zhao
    Luoting Yu
    Scientific Reports, 4
  • [42] KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
    Ciesielski, Michael J.
    Bu, Yahao
    Munich, Stephan A.
    Teegarden, Paola
    Smolinski, Michael P.
    Clements, James L.
    Lau, Johnson Y. N.
    Hangauer, David G.
    Fenstermaker, Robert A.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (03) : 519 - 527
  • [43] KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
    Michael J. Ciesielski
    Yahao Bu
    Stephan A. Munich
    Paola Teegarden
    Michael P. Smolinski
    James L. Clements
    Johnson Y. N. Lau
    David G. Hangauer
    Robert A. Fenstermaker
    Journal of Neuro-Oncology, 2018, 140 : 519 - 527
  • [44] SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)
    Wang, Lu
    Ai, Jing
    Shen, Yanyan
    Zhang, Haotian
    Peng, Xia
    Huang, Min
    Zhang, Ao
    Ding, Jian
    Geng, Meiyu
    CANCER LETTERS, 2020, 486 : 71 - 72
  • [45] Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
    Liu, M
    Bryant, MS
    Chen, JP
    Lee, SN
    Yaremko, B
    Lipari, P
    Malkowski, M
    Ferrari, E
    Nielsen, L
    Prioli, N
    Dell, J
    Sinha, D
    Syed, J
    Korfmacher, WA
    Nomeir, AA
    Lin, CC
    Wang, L
    Taveras, AG
    Doll, RJ
    Njoroge, FG
    Mallams, AK
    Remiszewski, S
    Catino, JJ
    Girijavallabhan, VM
    Kirschmeier, P
    Bishop, WR
    CANCER RESEARCH, 1998, 58 (21) : 4947 - 4956
  • [46] LY2801653: an Orally Bioavailable Small Molecule Kinase Inhibitor of MET with Inhibitory Activity Against the Oncoproteins ROS1 and MKNK1/2
    Thobe, M. N.
    Konicek, B. W.
    Peek, V. L.
    Baker, J. A. Roseberry
    Um, S. L.
    Graff, J. R.
    Walgren, R. A.
    Pei, H.
    Burkholder, T. P.
    Yan, S. B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 92 - 92
  • [47] TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK Profile
    Ohkubo, S.
    Muraoka, H.
    Hashimoto, A.
    Ito, S.
    Ito, K.
    Shibata, Y.
    Kanoh, A.
    Kitade, M.
    Yonekura, K.
    Utsugi, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 89 - 89
  • [48] Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
    Chan, Kwok-Ho
    Zengerle, Michael
    Testa, Andrea
    Ciulli, Alessio
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 504 - 513
  • [49] 3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer
    Sheng, Yuqiao
    Li, Wei
    Zhu, Feng
    Liu, Kangdong
    Chen, Hanyong
    Yao, Ke
    Reddy, Kanamata
    Lim, Do Young
    Oi, Naomi
    Li, Haitao
    Peng, Cong
    Ma, Wei-Ya
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (41) : 28192 - 28201
  • [50] Novel Selective Orally Bioavailable Small Molecule PAK4 Allosteric Modulators (PAMs) Display Anti-Tumor Activity in Vitro and in Vivo in Hematological Malignancies
    Senapedis, William
    George, Ryan
    McCauley, Dilara
    Ellis, Joel
    Crochiere, Marsha
    Savona, Michael
    Shacham, Sharon
    Landesman, Yosef
    Baloglu, Erkan
    BLOOD, 2014, 124 (21)
12345